Judging by the fact that Sanofi SA (ADR) (NYSE:SNY) has experienced declining sentiment from the entirety of the hedge funds we track, it’s easy to see that there exists a select few hedge funds that slashed their positions entirely during …
NEW YORK, October 20, 2017 /PRNewswire via COMTEX/ -- NEW YORK, October 20, 2017 /PRNewswire/ -- New …
Sanofi and MannKind launched a $925 million partnership in 2014 to market Afrezza, an inhalable form of insulin, shortly after it was approved. (For more, see Is This Diabetes Stock a Better Bet Than MannKind?) At the time, the market for …
As for each quarter, Sanofi prepared this document to assist in the financial modeling of the Group's quarterly results. This document includes a reminder on various non-comparable items and exclusivity losses as well as the foreign currency …
The analyst in Paris also doubted the news would be reflected in Sanofi's stock price. The stock has risen 18.5 percent since the beginning of the year. Sanofi closed today at 372.1 francs, down 3.3 francs, or 0.9 percent.
Keith Speights: One of the ways, at least from an outsider looking in, that you've …
NWI3d
Paris, France - June 15, 2017 - Sanofi announced today the launch of "Action 2017", a worldwide stock purchase plan reserved for its employees. In doing such a capital increase, Sanofi intends to better associate its employees with the …
The shares were up 3.9 percent at 209.80 Swiss francs by 0914 GMT, while Sanofi stock edged up 0.1 percent. Actelion's share price had fallen more than 7 percent in the past two sessions as a hoped-for takeover valuing the Swiss biotech …
Merck is a Zacks Rank #3 (Hold) stock - you can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Sanofi Signs MS Deal worth up to $805M: Sanofi (SNY - Free Report) has entered into an agreement with …